Cardima, Inc. Announces Launch of New Family of Guiding Catheters.FREMONT, Calif.--(BW HealthWire)--Feb. 11, 1998--Cardima(tm), Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CRDM CRDM Control Rod Drive Mechanism CRDM Centre for Rapid Design and Manufacture (Buckinghamshire Chilterns University) CRDM Cumann Rince Dea Mheasa (Irish dancing organisation) ), today announced the launch of a new family of guiding catheters, the Venaport(tm) LR for Long Reach, designed specifically for accessing major veins in the heart. The Venaport LR family will include a variety of new tip shapes and longer reach distal ends which are designed to provide not only easier access to the main coronary vein coronary vein n. Any of the veins that drain blood from the muscular tissue of the heart and empty into the coronary sinus. , the coronary sinus coronary sinus n. A short trunk receiving most of the veins of the heart, running in the posterior part of the coronary sulcus and emptying into the right atrium between the inferior vena cava and the atrioventricular orifice. , but will also provide additional stability to maintain its positioning while the physician manipulates the electrophysiology catheter through the guide. Phil Radlick, Ph.D., President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Cardima said, "We have further broadened our product offering with the family of Venaport LR guides to fulfill the physician's need for faster access to the coronary sinus, to diagnose ventricular tachycardia Ventricular Tachycardia Definition Ventricular tachycardia (V-tach) is a rapid heart beat that originates in one of the lower chambers (the ventricles) of the heart. (VT), a potentially life-threatening condition that affects over two million people throughout the world today. It is important for physicians to be able to access this vasculature vasculature /vas·cu·la·ture/ (vas´ku-lah-chur) 1. circulatory system. 2. any part of the circulatory system. vas·cu·la·ture n. to diagnosis VT safely and quickly. Cardima is the only company providing microcatheters that are able to diagnose VT using the blood vessels located in the walls of the heart." Cardima, Inc. designs, develops, manufactures and markets minimally invasive, single-use microcatheter-based systems for the dual purpose of finding and treating the two most common forms of cardiac arrhythmias: atrial fibrillation, a condition of the heart characterized by the irregular and very rapid beating of the heart's atrial atrial /atri·al/ (a´tre-al) pertaining to an atrium. a·tri·al adj. Of or relating to an atrium. Atrial Having to do with the upper chambers of the heart. chambers and ventricular tachycardia, a life-threatening condition in which heartbeats are improperly initiated from within the ventricular walls, bypassing the heart's normal conduction system. Cardima is the only company developing unique microcatheters to be used in diagnosing and treating VT from within the wall of the heart. Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties include, without limitations, those set forth in the Company's Registration Statement on Form S-1 and periodic reports filed with the Securities and Exchange Commission, and the Company's ability to conduct successful clinical trials, obtain timely regulatory approvals and gain acceptance from the marketplace for its products. CONTACT: Cardima Ron Bourquin, 510/354-0162 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion